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Welcome to this new issue of the Journal of Hematopa-
thology, the fourth and final one of 2009. We have thus
completed volume 2, which I hope has been interesting.
This issue contains another review on the 2008 WHO
classification, which I trust you will find as useful as the
previous ones, on which we received many positive
comments. Now that we are getting used to the WHO
book it is interesting to see how highly respected this book
is. And rightly so, for it brings together the knowledge on
hematological neoplasms and guides us with a classifica-
tion. It is, however, a guide, and like any guide, things have
already changed by the time it gets published. It is also a
multi-author book with many contributors. Although the
editors did an excellent job in harmonizing the chapters, it
should not be a surprise that there are differences among
some of them. It is a book to read and understand, but not
to spell out every word. I sometimes get the impression that
the text is taken too much as law written in stone. It remains
important to go to the literature, new and old, and to use
textbooks. More importantly, one needs to realize that it is
work in progress.
The first decade of this century has now passed. We have
seen many developments in medicine. In the year 2000 it
was noted that we had entered an era where cancer would
become a chronic disease, based on the knowledge
explosion with regard to its biology. We are certainly
seeing a major change: indeed, medicine has become
molecular and evidence based, and drugs that target
molecular pathways have become available. We see
improvement for patients suffering from specific forms of
hematological cancer, but we still have a long way to go.
Our task as hematopathologists remains to diagnose disease
processes accurately, and to achieve that we need increas-
ingly molecular techniques. It is crucial that we implement
these techniques with good knowledge of the possibilities
and pitfalls, and we need reliable quality assurance systems.
We also need to work in close collaboration with
cytogeneticists and immunologists. The coming decade
will be one of bringing bench to bedside, and hematopa-
thologists will play a crucial role in that.
But in the end, like in the previous century and the
decade just past, also in the next decade we will perform
our work for people that suffer from disease, either indolent
or aggressive, either with good outcome or bad. It is for
them that we need to know more about the pathogenesis,
and it is for them we implement new techniques, write
papers, and create journals. To know that remains a
rewarding inspiration.
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